Oncolytic Virus Therapy with HSV-1 for Hematological Malignancies

Oncolytic herpes simplex virus type 1 (HSV-1) has been investigated to expand its application to various malignancies. Because hematopoietic cells are resistant to HSV-1, its application to hematological malignancies has been rare. Here, we show that the third generation oncolytic HSV-1, T-01, infec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther
Main Authors: Ishino, Ryo, Kawase, Yumi, Kitawaki, Toshio, Sugimoto, Naoshi, Oku, Maki, Uchida, Shumpei, Imataki, Osamu, Matsuoka, Akihito, Taoka, Teruhisa, Kawakami, Kimihiro, van Kuppevelt, Toin H., Todo, Tomoki, Takaori-Kondo, Akifumi, Kadowaki, Norimitsu
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7854286/
https://ncbi.nlm.nih.gov/pubmed/33038943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2020.09.041
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados